Korea Investment Corp’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,875
Closed -$251K 767
2022
Q2
$251K Buy
4,875
+4,175
+596% +$216K ﹤0.01% 749
2022
Q1
$52K Sell
700
-13,700
-95% -$1.22M ﹤0.01% 742
2021
Q4
$2.06M Sell
14,400
-100
-0.7% -$17.2K 0.01% 650
2021
Q3
$3.01M Buy
14,500
+1,100
+8% +$242K 0.01% 614
2021
Q2
$2.85M Buy
+13,400
New +$2.46M 0.01% 640

Other funds holding NVAX

Korea Investment Corp's NVAX Position: Q3 2022 in Review

Korea Investment Corp sold out of Novavax (NVAX) in Q3 2022, closing a stake of 4,875 shares — an estimated $251K sold.

Korea Investment Corp first reported a position in NVAX in Q2 2021 and held it in 5 quarters. The position peaked at $3.01M in Q3 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Korea Investment Corp reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Korea Investment Corp sold 4,875 Novavax shares in Q3 2022, an estimated $251K.
  • Korea Investment Corp first reported a position in Novavax in Q2 2021 and held it in 5 quarters.
  • Korea Investment Corp's Novavax position peaked at $3.01M in Q3 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Korea Investment Corp's 13F filing for Q3 2022, filed 10 Nov 2022.